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Abstract 
 
The synthesis, characterization and liposome insertion of a novel 
magnesium(II) carboranyl-porphyrazine, i.e. [2,3,7,8,12,13,17,18-octakis-(1,2-
dicarba-closo-dodecaboranyl)-hexylthio-5,10,15,20-porphyrazine]magnesium(II) 
complex, MgHECSPz, is described. MgHECSPz was designed to improve the 
potentiality in multiple approach anticancer therapy. Liposomal formulations with 
different surface charge were prepared as delivering agents. The obtained loaded 
vectors were characterized by DLS, SAXS, SANS and ζ potential measurements in 
order to define the overall properties and structural details of loaded liposomes. 
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1. Introduction 
 
A new approach for drug design must be based on the idea to combine 
multiple functionalities in one molecule or in its complex with the proper delivery 
vector. This way, it is possible to access different therapies with a single drug 
administration. Inside this scenario, Boron Neutron Capture Therapy (BNCT) [1-3] a 
two-step cancer treatment initially designed for radio-resistant highly invasive tumors, 
and for those not removable by surgery is nowadays acquiring a renovated potential. 
In particular, the BNCT strategy can be applied to pathologies such as gliomas in the 
brain and superficial cancers, coupled to Photodynamic and Photothermal Therapies 
(PDT and PTT, respectively) [4,5]. 
In order to be effective for BNCT, delivery of a large number of boron atoms is 
necessary, i.e. ∼109 nuclei of 10B per tumor cell [6]. The new generation of products 
investigated in the research on BNCT includes a large variety of carborane 
derivatives [7], where the icosahedral carborane cage has been linked to nucleic 
acids [8,9], sugars  [10-12], porphyrins and related macrocycles [13-15].  
In this paper, a novel magnesium(II) polycarboranylporphyrazine, i.e. 
[2,3,7,8,12,13,17,18-octakis-(1,2-dicarba-closo-dodecaboranyl)-hexylthio-5,10,15,20-
porphyrazine]magnesium(II) (henceforth called MgHECSPz) (Figure 1) was 
synthesized and thoroughly characterized by conventional methods. The fact that 
carboranylporphyrazines may conjugate a high degree of peripheral carboranyl 
substitution with the peculiar electronic properties of the porphyrazinethiolate core 
motivated our choice. Indeed, these small-ring tetrapyrroles, depending on the nature 
of the peripheral substituents and the coordinated metal, show intense to very 
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intense absorbance in the “therapeutic window”, near-IR luminescence, or rapid 
radiationless decay of the primarily excited S1(Q) state [14,16]. 
Liposomes came into focus as valuable drug carriers and delivery systems 
because of their versatility and compatibility with respect to physiological 
environments [17]. In particular, for the specific application of porphyrins and related 
compounds [18], liposomes turned out to be capable of decreasing the tendency 
toward aggregation that strongly affects these photosensitizers and reduces their 
activity [19-21].  
In this work liposome formulations with different surface charge were chosen 
for insertion of MgHECSPz in the lipid bilayer. The same long and flexible 
unsaturated dioleoyl chains were selected and used in all formulations in order to 
accommodate the bulky MgHECSPz molecule (~40 Å in its extended form). Plain and 
loaded vectors were characterized in term of structure and size by small angle 
neutron scattering (SANS), zeta potential (ζ), and dynamic light scattering (DLS). 
Details at the bilayer level were obtained by small angle X-ray scattering (SAXS). 
 
 
2. Materials and methods 
 
2.1. Materials 
All chemicals and solvents (Aldrich Chemicals Ltd.) used in the syntheses 
were of reagent grade and used as supplied. o-carborane was purchased from 
Ryskor Science, Inc. (USA). Solvents used in physical measurements were 
spectroscopic or HPLC grade. Diethyl ether and tetrahydrofuran (THF) were freshly 
distilled from sodium benzophenone ketyl under nitrogen. 1,2-dioleoyl-3-
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trimethylammonium-propane (chloride salt) (DOTAP, purity >99%), 1,2-dioleoyl-sn-
glycero-3-phosphate (monosodium salt) (DOPA, purity >99%), and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE, purity >99%), were purchased from Avanti 
Polar Lipids, Inc., Alabaster, AL, and used without further purification. 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC, purity >99%) was purchased from Northern Lipids, 
Inc., Vancouver, CA. 
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2.2. Liposome preparation 
Liposomes were prepared from a 1:1 molar ratio mixture of two di-oleoyl lipids, with 
different polar heads. One component was the helper lipid DOPE in all formulations. 
It has been shown that DOPE gives higher transfection efficiency, since it is able to 
form columnar inverted hexagonal, HIIC, structures, having higher fusogenic 
properties with respect to the lamellar structures (Lα), usually formed by lipids with 
phosphocholine head groups (PC) [22-24]. The second lipid in the 1:1 mixture was 
varied among the zwitterionic DOPC, the cationic DOTAP, and the anionic di-oleoyl-
glycero-phosphate DOPA in the form of monosodium salt. For each formulation, 
three different samples were prepared: 1) pure liposome; 2) liposome containing 
2.1x10-4 mol/L starting porphyrazine (MgHECSPz: lipid = 1 : 200); 3) liposome 
containing 4.2x10-4 mol/L starting porphyrazine (MgHECSPz : lipid = 1 : 100). The 
total lipid content was 4.2x10-2 mol/L in each sample. 
Lipid dry powders were dissolved in chloroform and mixed in 1:1 ratio to obtain 
different liposomes formulations. The solvent was then evaporated to dryness under 
vacuum overnight. The resulting film was swollen at room temperature with MilliQ 
grade water. SANS samples were prepared in 99.9 % D2O (SIGMA). Upon vortexing, 
multilamellar vesicles were obtained and were submitted to eight cycles of freeze and 
thaw. Final downsizing and conversion to unilamellar vesicles was obtained by 
extrusion through 100 nm polycarbonate membranes with the LiposoFast apparatus, 
Avestin, Ottawa, CA. 3.2. For the systems studied in this work, the employment of 
extrusion membranes with pore diameter smaller than 100 nm frequently led to the 
rupture of the membrane itself, with consequent lack of sample reproducibility. This 
was attributed to the impossibility of increasing the bilayer curvature above a certain 
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extent in the experimental conditions (i.e. type of guest molecule, concentrations etc.) 
used.  
 
2.3. Methods 
1H and 13C NMR data were recorded at 499.58 and 125.62 MHz, respectively, 
on an INOVA Varian 500 MHz spectrometer. 11B NMR data were recorded at 128.32 
MHz on a Varian VNMRS-400 MHz spectrometer. Chemical shifts (δ) are expressed 
in parts per million (ppm). Coupling constants (J) are in Hz. The 1H and 13C NMR 
chemical shifts are relative to tetramethylsilane (TMS); peaks of the residual protons 
from the solvents were used as internal standards for 1H (δ 7.20 chloroform) and all-d 
solvent peaks for 13C (δ 77.0 chloroform); the 11B NMR chemical shifts are relative to 
external BF3·OEt2. All measurements were carried out at 298 K.  
Infrared (IR) spectra were measured with a FT/IR-460-Plus JASCO 
spectrometer. Electronic absorption spectra were recorded using a UV-VIS-NIR 
Varian Cary 05E double-beam spectrophotometer. GC-MS spectra were measured 
with a Hewlett-Packard 6890 instrument.  
Zeta potential measurements were performed with a Coulter DELSA 440 SX 
(Coulter Corporation, Miami, FL, USA). ζ was automatically calculated from the 
electrophoretic mobility by means of the Helmholtz-Smoluchowski relation. All 
samples were diluted 60 times to meet the instrumental sensitivity requirements. At 
least two different runs were carried out for each sample and all adducts showed a 
unimodal distribution of the ζ values.  
Size measurements were performed by DLS with a Coulter Sub-Micron 
Particle Analyzer, Model N4SD, equipped with a 4 mW helium-neon laser (632.8 nm) 
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and 90° detector. Mean diameter and polydispersity index, (μ/γ2)2, of plain and drug-
loaded liposomes were thus obtained. 
Small Angle X-ray Scattering (SAXS) spectra were recorded on a high 
sensitivity pinhole camera with home built collimating optics and a rotating anode (Cu 
Kα) as the radiation source [25]. Samples were put into flat cells having 1 mm 
thickness and NalophanTM windows. The accumulation time was 30 min. Details on 
the experimental setup and curve fitting are reported elsewhere [11].  
Small Angle Neutron Scattering (SANS) experiments were performed on the 
research nuclear reactor ORPHEE, using the PAXY instrument of the Laboratoire 
Léon Brillouin (Saclay, France). Three different configurations were used (λ = 12 Å, D 
= 5 m;  λ = 4 Å, D = 5 m; λ = 4 Å, D = 1m, where λ is the neutron wavelength and D 
the sample-detector distance). The overall q-range obtained was 0.0047–0.55 Å-1. 
SANS diagrams were reduced to the absolute scale and the intensity at large angles 
(incoherent background) was subtracted before data analysis.  
 
 
3. Results and discussion 
 
3.1. Synthesis of MgHECSPz 
MgHECSPz was synthesized with a five-steps procedure as shown in the 
following scheme: 
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This procedure presented some modifications with respect to literature [14, 
26,27]. More details on the synthetic procedure, the analytical characterization of the 
intermediates and on the final product will be published elsewhere. With these first 
three steps, the intermediates silyl-o-carborane (2), 6-(silyl-o-carboranyl)-1-
bromohexane (3), and 6-(o-carboranyl)-1-bromohexane (4) were obtained in very 
good yields from 1,2-dicarba-closo-dodecaborane (1). Characterization data (mass 
spectra, 1H-, 13C, 11B-NMR, and IR spectra) of these compounds well agreed with 
similar compounds described in the literature [28,29]. The MgHECSPz precursor, the 
cis-2,3-bis[6-(1,2-closo-dodecarboranyl)hexylthio] maleonitrile, 5, was obtained in 
~20% yield by reaction of 4 with dimercaptomaleonitrile disodium salt at room 
temperature. Characterization data for 5, including elemental analyses, were fully 
consistent with the expected structure confirming, in particular, that the o-carborane 
cages retain the closo structure in the compound. Cyclotetramerization of 5 on 
MgII(n-OPr)2 (step 5) via a nucleophilic attack of the MgII(n-OPr)2 on the o-carborane 
moieties proved to be the critical synthetic step. In this step degradation of the 
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peripheral o-carboranes with formation of anionic (nido) species might occur [30]. 
However, we found that the impact of this process can be significantly attenuated by 
using mild reaction conditions (T < 115 °C) and a relatively short reaction time 
(~10h). Such procedure, though implying incomplete conversion of 5 (~ 30% of 
unreacted 5 can be retrieved), had the merit to reduce the formation of carborane-
based byproducts, which could hardly be separated from the desired porphyrazine by 
chromatography.  
Pure MgHECSPz was found to be insoluble in water either as monomer or in 
the form of aggregates. 
The integrity of the eight o-carborane cages in the complex was confirmed by 
elemental analyses, and by 1H-, 13C-, 11B-NMR, ESI MS, and IR spectra. In 
particular, the 13C NMR spectrum showed two resonances at δ = 63.6 ppm and δ = 
40.2 ppm which are the signature of the C-H and C-R (R = hexyl, in the actual case) 
carbons, respectively, belonging to a neutral closo-carborane cage [26,27]. In turn, 
the IR spectrum showed the symmetric and intense peak at 2588 cm-1, attributable to 
the B-H stretching vibration of the closo o-carborane cage [27,29]. 
MgHECSPz exhibited the typical UV-Vis spectrum of alkylthioporphyrazines 
[16] in DMF, with relatively intense Q and B bands peaking at 671 nm and 384 nm, 
respectively, and a broad band due to nsulfur→π* transitions in between (502 nm). The 
optical spectrum of MgHECSPz solubilized in weakly coordinating solvents, such as 
chloroform (Figure 2), showed a clearly split Q-band and a blue shifted B-band. This 
suggested that the complex had a marked tendency to give dimers or even larger 
aggregates in hydrophobic environments, most likely by setting up effective Mg…S 
intermolecular interactions.  
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 Aggregation could be promptly disrupted, however, upon addition of a minimal 
amount (<1% v/v) of a coordinating solvent, such as methanol or pyridine (Figure 2). 
Quite interestingly, the “monomeric” form of the complex could also be restored upon 
addition of an equimolar amount of phospholipid. This behavior, which was in line 
with the well documented tendency of MgII porphyrazines to axially coordinate even 
relatively weak σ-donor ligands, such as water [29], suggested that the complex, 
when incorporated in the liposomal matrix, set up interactions with the polar heads of 
the lipids, particularly with the phosphate groups. This finding was also in agreement 
with the behavior of similar non metallated tetra-aza macrocycles [14]. 
 
3.2. Loding of MgHECSPz into liposomes 
MgHECSPz was added in the desired concentration from a 2x10-3 M stock 
solution in CHCl3 to the mixed lipid solution in the same solvent. Porphyarzine 
containing liposomes then were prepared following the same procedure described in 
section 2.2 for plain liposomes.  
The rate of MgHECSPz loading was determined as described earlier [14]. It 
was found to be in the range 6-12% of added MgHECSPz, independently of lipid 
formulation and starting porphyrazine content.  
 
3.3. Characterization of loaded liposomes 
 
A) Zeta potential analysis. Figure 3 shows the Zeta Potential values of the different 
liposome systems as a function of nominal porphyrazine concentration. Pure 
DOTAP/DOPE liposomes had a Zeta Potential value of +45(±5) mV, as expected for 
the presence of the cationic lipid DOTAP. On the other hand, the Zeta Potential was 
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–65(±10) mV for pure DOPA/DOPE, because of the negatively charged DOPA. For 
DOPC/DOPE liposomes the measured ζ value was –5(±1) mV. This meant that the 
zwitterionic liposomes used in this study behaved as slightly negatively charged 
objects in water solution and that, at molecular level, the phosphate groups were 
more exposed than the choline moieties on the outer surface of liposomes.  
In MgHECSPz-DOTAP/DOPE systems the Zeta Potential decreased with 
increasing porphyrazine concentration, while it increased in DOPA/DOPE and 
DOPC/DOPE series. This confirmed the insertion of the porphyrazine in all liposome 
formulations. At the same time either the decrease or the increase of ζ suggested 
that MgHECSPz (not charged) was able to dilute the liposome surface charge upon 
insertion in the bilayer region. In particular, for the DOPC/DOPE series, Zeta 
Potential inverted its sign by increasing the porphyrazine content from the slightly 
negative value of pure liposomes toward positive values. For this formulation, the 
results were more variable with respect to the other type of liposomes, and 
sometimes negative values were obtained for both plain and porphyrazine-loaded 
liposomes.  
Table 1 shows the diameter and the polydispersity index of the same systems 
reported in Figure 3, as measured by dynamic light scattering. 
Pure liposome diameters were slightly larger than 100 nm, as expected from 
the preparation procedure. In the DOTAP/DOPE and DOPA/DOPE series, liposome 
size and polydispersity slightly increased with increasing porphyrazine concentration. 
For DOPC/DOPE liposomes the insertion of MgHECSPz induced a stronger effect, if 
compared with the other formulations. This difference was in line with the trends 
described for Zeta Potential values. The peculiarity of size growth observed for 
DOPC/DOPE formulation was related to the properties of the phosphocholine head 
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group, which presents a stronger tendency to stack into multilamellar structures with 
respect to other types of polar head. The insertion of the porphyrazine ring enhanced 
this tendency, as confirmed for similar molecules in the same lipid formulation [14].  
 
B) SAXS analysis. Figure 4a shows the evolution of SAXS profiles for plain and 
MgHECSPz-loaded DOPA/DOPE liposomes as a function of the porphyrazine 
starting concentration. To fit these curves, the form factor of a bilayer was used:  
 
2
,,,,4 )]2
2sin()()
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sin()[(4)( chesehcehec
ttqtq
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qI +−+−Σ= ρρρρπ    (1) 
 
where cρ , hρ , tc and th are the electronic density and the thickness of the hydrophobic 
and hydrophilic layer, respectively; sρ  is the electronic density of the solvent and Σ 
the interface extension per unit volume [31]. A Gaussian distribution of the bilayer 
hydrophobic thickness (with half-width at half maximum δtc) allowed to take into 
account a certain degree of polydispersity. The corresponding fittings are reported in 
Figure 4b-d and the best-fit parameters are listed in Table 2. A trend could be 
evidenced and it was consistent with an increase in bilayer thickness and 
polydispersity at increasing porphyrazine content. In particular, a sort of bilayer 
swelling upon drug addition occurred, probably due to the bulky structure of the 
porphyrazine used in this study. The above results were also in agreement with those 
obtained by Zeta Potential and DLS measurements, which gave an analogous trend 
for the overall properties (i.e. surface charge and mean size) of plain- and 
porphyrazine-loaded liposomes. 
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Contrarily to what happened for negative liposomes, in the cationic 
DOTAP/DOPE series the bilayer did not appear to be influenced by porphyrazine at 
the lipid/MgHECSPz loading ratios investigated in this works (data not shown). In 
fact, the differences between the SAXS diagrams of plain- and MgHECSPz-loaded 
liposomes were superimposed within the limits of experimental error. A unique fitting 
curve reproduced the general trend. The corresponding best-fit parameters are 
reported in Table 2.  
The SAXS profiles of the zwitterionic liposomes, with and without added 
MgHECSPz are reported in Figure 5. These systems showed a peculiar behaviour 
with respect to either positively or negatively charged starting liposomes, because 
the insertion of the porphyrazine molecules induced partial formation of multilamellar 
vesicles. 
The presence of these latter structures was clearly established by the 
appearance of Bragg peaks, superimposed to the diffuse scattering curve of 
monolamellar liposomes. In particular, the first two reflections of the (l00) lamellar 
stacking were detected, from which the interlamellar distance d = 2π/q0 could be 
calculated (q0 is the position of the first order Bragg peak). The formation of pauci-
lamellar structures in extruded liposomes has been reported in the literature. For 
instance, Kucerka et al. [32] have studied and modeled the extent of this 
phenomenon as a function of vescicle size and bilayer net charge by doping DOPC 
liposomes with the negative lipid DOPS.  
The value obtained for interlamellar distance in the present systems (61.5 ± 
0.5 Å) was in agreement with the literature [33]. The occurrence of partial stacking in 
DOPC/DOPE liposomes was also in agreement with the high polydispersity values 
found for the vesicle overall size by DLS measurement, as reported in Table 1. This 
 15
effect was ascribed to the well known tendency of porphyrin-like macrocycles to 
stack on top of each other, especially when in the presence of water or another polar 
solvent. In these conditions porphyrins and related macrocycles tend to form dimers 
or larger columnar aggregates, as widely reported in the literature [20,21] and as 
discussed in section 3.1 of this paper.  
Pure DOPC/DOPE liposomes were monolamellar and their SAXS profile was 
fitted with the usual procedure followed in this work. The corresponding best-fit 
parameters are listed in Table 2. More detailed information on the fine structure of 
systems where monolamellar and pauci-lamellar structures coexist in solution could 
be obtained by extensive SAXS data treatment and curve fitting [32,34]. In particular, 
Nallet et al. [34] have obtained the bilayer elastic constants, as well as an estimation 
of the number of lamellae, in binary lyotropic smectics, which show diffuse scattering 
underlying Bragg peaks. These authors have built up a model that takes into account 
both the membrane geometry and the thermodynamic origin of the layer 
displacement fluctuations. 
. 
C) SANS analysis. The experimental SANS patterns of plain and MgHECSPz-loaded 
liposomes were fitted by using the complete form factor of monolamellar vesicles 
Pves, with a homogeneous bilayer contrast:  
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with f(q(R+t)) and f(qR) in the form: 
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where R is the inner radius of the vesicle and t = 2th + tc the total bilayer thickness. 
Note that, unlike SAXS, SANS probes mainly the hydrophobic core region, whereas 
the hydrated head groups contribute much less to the scattering. The scattered 
intensity I(q) then reads: 
 
ves
2 P
V
n)q(I ρΔ=       (3) 
 
where Δρ is the average neutron scattering length density difference between the 
vesicle components and the deuterated solvent (SANS contrast), n/V is the number 
density of scattering objects, i.e. the number of vesicles per unit volume, which is 
directly related to the volume fraction for vesicles of a given size.  
All fits were carried out by using the form factor in eq. (2), integrated 
numerically over a Gaussian distribution function in radius (with standard deviation 
σR), in thickness (with standard deviation σt), and convoluted with the resolution 
function of the instrument [35,36]. 
In the case of SANS, the theoretical shape of vesicle scattering curve (Eqs. 2-
3) would be the following [37]: at small q values, there should be no relevant 
contribution from the interaction among different vesicles, given the low 
concentrations used in this work, and the intensity should start from a value 
proportional to the total surfactant mass. As q increases, the intensity decreases 
proportionally to exp (-q2Rg2/3), where Rg is the radius of gyration of the vesicle, i.e. 
roughly the radius of these thin shell objects. At intermediate q, the intensity is 
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proportional to q-2, which is the characteristic power law for bilayer scattering. This 
was what we observe in Figure 6 and 7, where no Guinier plateau was found at low 
q, indicating that the vesicles were too large for our experimental q-range. The radius 
measured in DLS was thus taken as an input parameter for the fitting although, as 
explained below, this did not necessarily produced the best fit. At high q, a second 
power law was found, proportional to q-4, which is the Porod scattering from the 
surface.  
Figure 6 shows the SANS curve of DOTAP/DOPE liposomes and the 
corresponding best fit. As in the case of SAXS, no large differences could be 
detected between plain and porphyrazine-loaded DOTAP/DOPE liposomes. The 
fitting was carried out with the parameters listed in Table 3. In particular, the radius 
value was obtained from DLS measurements and the thickness value was 35 Å with 
a half-width at half maximum of σt = 3 Å for the Gaussian distribution. This size and 
degree of polydispersity reproduced the features of experimental curves at large q-
values, e.g. the 'kink' located at ≈ 2π/35 Å, in a satisfying manner. Contrarily to the 
SAXS analysis, which concentrated on the bilayer profile, the lower-q data of the 
SANS investigation allowed to capture the q-2 power law which is characteristic of 
large-scale bilayer scattering, as mentioned above.  
Essentially the same analysis could be carried out for plain and MgHECSPz 
loaded DOPC/DOPE liposomes. The corresponding fitting values are also reported in 
table 3. It is to be noted that in the case of loaded DOPC/DOPE liposomes, SANS 
patterns did not show the presence of pauci-lamellar structures, which were 
evidenced by SAXS curves as shown in Figure 5. This suggested that the amount of 
this kind of structures was limited, and that only the SAXS sensitivity toward the 
bilayer properties could reveal their presence. 
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The SANS curves of negatively charged DOPA/DOPE liposomes showed a 
slightly different behavior (Figure 7), since at low-q, an evolution in the large-scale 
structure of vesicles was found. Although the fitting could be done with the same 
procedure used for cationic and zwitterionic liposomes, that is by taking the outer 
radius from light scattering measurement, the corresponding fitting gave poor 
reproduction of the experimental data in the low-q region. This pushed us to choose 
a different approach, that is let the vesicle size be varied instead of being constrained 
to the value obtained by DLS measurements .  
For pure DOPA/DOPE, the SANS curve showed almost no structure at low angles. 
Fitting this curve with the radius taken from DLS (600 Å, σR = 60 Å), allowed to obtain 
some low-q oscillations not visible in the SANS-data and it was necessary to 
increase the radius till about 1000 Å and introduce a high polydispersity in radius 
(200 Å), in order to obtain scattering curves compatible with the experimental data, 
as the one shown in Figure 7b. Note that we fixed the volume fraction to the value 
used for the SAXS fitting ( φ = 2.5%, cf. Table 2). The prefactor of the intensity was 
then governed by the average contrast of the bilayer, cf. eq.(3), and in the fit of 
Figure 6b Δρ = 6.6 1010 cm-2 was used. This corresponded to a scattering length 
density of – 0.2 1010 cm-2 of the bilayer core, in good agreement with previous results 
[11]. As 2 10-4 M of MgHECSPz was added, the intensity curve showed some very 
weak oscillations at low-q. Again, as we did not have access to sufficiently low-q 
data, in order to reach the Guinier regime, we first tried the radius obtained from DLS 
(650 Å, σR = 60 Å), which also predicted weak oscillation, but considerably out of 
phase with respect to the observed one. Decreasing the inner radius to 535 Å with, 
as before, a rather large polydispersity in radius (120 Å), we could reproduce the 
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scattered intensity rather well, apart from a slight overestimation of the intensity at 
low angles (Figure 7c). As in the case of the pure DOPA/DOPE sample, we kept the 
same volume fraction used for the SAXS treatment ( φ = 2.7%, cf. Table 2), and 
adjusted the bilayer contrast for a good fit (Δρ = 6.4 1010 cm-2). This corresponded to 
a difference of less than five percent with respect to pure DOPA/DOPE, which is an 
adequate deviation, since the commonly accepted error is 5 to 10 % in determining 
the absolute units. We should also mention that the insertion of MgHECSPz 
corresponded to calculated undetectably small change in the scattering length 
density of the bilayer (less than 1%).  
The DOPA/DOPE data set with starting 4x10-4 M of MgHECSPz also showed an 
oscillation at low q, which was not reproduced by using the radius obtained from DLS 
(750 Å, σR = 60 Å). On the contrary, a lower (inner) radius of 485 Å with a 
polydispersity in radius of σR = 80 Å yielded the fitting shown in Figure 7d. Again the 
low-q intensity was slightly too high, but the position of the oscillations and the 
general shape of the curve could be reproduced in a satisfactory manner. As with the 
previous two data sets, the volume fraction was fixed ( φ = 2.8%, cf. Table 2), and a 
bilayer contrast of Δρ = 6.4  1010 cm-2 was used for the fit plotted in Figure 6d.  
As it can be seen from the values reported in Table 3, the SANS patterns did 
not change significantly at intermediate and high q within each series. This indicated 
that no relevant effect could be evidenced by SANS upon porphyrazine insertion in 
the liposome bilayers. The thickness of the bilayers was slightly smaller than the 
value obtained from SAXS measurements and this was ascribed to the hydration of 
the bilayer, which brings about differences in the contrast for the two small angle 
scattering techniques [38]. In summary, for the DOPA/DOPE series, vesicles seemed 
to shrink with porphyrazine-loading, and become more monodisperse. One may note 
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that the scattered intensities systematically overestimate the intensity in this q-region. 
This could be the signature of some weak interaction between vesicles, i.e. the 
intensity may be suppressed by the inter-vesicle structure factor. If we estimate the 
order of magnitude, vesicles of radius 600 Å at 3% are typically at a center-to-center 
distance of 1750 Å. This was just outside our window of observation (2π/1750 Å= 3.6 
10-3 Å-1), and it is possible that weak repulsion among vesicles induced some 
suppression in the low-q scattering.  
 
 
4. Conclusions 
 
In this paper, we described characterization of a magnesium(II) complex of a 
novel polycarboranylporphyrazine, MgHECSPz, and its insertion in different liposome 
formulations and the resulting adducts. 
Insertion was reported by the change in several physico-chemical parameters 
of liposomes, e.g. their size and polydispersity, Zeta Potential and bilayer thickness. 
The overall effect observed upon loading was a small change in the liposome size 
and polydispersity, as well as a dilution of the charge. This latter factor agreed with 
the trend of the Zeta Potential values in the different systems. SAXS and SANS 
analysis showed that only the anionic DOPA/DOPE liposomes exhibited a definite 
trend of varying size and bilayer thickness with increasing MgHECSPz content.  
The most relevant result of the present study was that in all cases the 
structure and bilayer properties of loaded liposomes were not drastically changed. 
This is a favorable starting point for possible applications of these systems in the 
biomedical field. 
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Table 1. Diameter and polydispersity index of the investigated 
liposomes. 
Sample Diameter (nm) Polid. index 
Pure DOTAP/DOPE 112(±4) 0.045 
DOTAP/DOPE 
+ MgHECSPz = 2.1×10-4 M 
120(±5) 0.079 
DOTAP/DOPE 
+ MgHECSPz = 4.2×10-4 M 
126(±5) 0.073 
Pure DOPC/DOPE 120(±4) 0.090 
DOPC/DOPE 
+ MgHECSPz = 2.1×10-4 M 
218(±8) 0.43 
DOPC/DOPE 
+ MgHECSPz = 4.2×10-4 M 
190(±7) 0.41 
Pure DOPA/DOPE 117(±4) 0.093 
DOPA/DOPE 
+ MgHECSPz = 2.1×10-4 M 
150(±5) 0.20 
DOPA/DOPE 
+ MgHECSPz = 4.2×10-4 M 
150((±5) 0.29 
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Table 2. Best fit parameters for plain- and porphyrazine-loaded liposomes. 
Sample φ ρc (cm-2) ρh (cm-2) tc (Å) δtc (Å) rh(Å) tbil (Å) 
Pure DOTAP/DOPE 0.025 7.6×1010 1.32×1011 28.0 0.5 5.4 39.6 
Pure DOPC/DOPE 0.025 7.6×1010 1.26×1011 27 1.0 7.5 42 
Pure DOPA/DOPE 0.025 7.6×1010 1.38×1011 25.0 0.3 6.0 39.0 
DOPA/DOPE 
+ MgHECSPz = 
2.1×10-4 M 
0.027 7.5×1010 1.41×1011 27.6 0.5 6.5 40.6 
DOPA/DOPE 
+ MgHECSPz = 
4.2×10-4 M 
0.028 7.2×1010 1.43×1011 28.3 0.6 7.2 42.7 
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Table 3. Fit parameters for SANS curves. 
Sample Inner radius (Å) σR (Å) Bilayer thickness (Å) 
(σt = 3 Å) 
Pure DOTAP/DOPE 600 50 35 
DOTAP/DOPE 
+ MgHECSPz 2.1×10-4 M 
600 60 35 
DOTAP/DOPE 
+ MgHECSPz 4.2×10-4 M 
650 60 35 
Pure DOPC/DOPE 600 50 34 
DOPC/DOPE 
+ MgHECSPz 2.1×10-4 M 
1000 60 34 
DOPC/DOPE 
+ MgHECSPz 4.2×10-4 M 
1000 80 35 
Pure DOPA/DOPE 1000a 200a 35 
DOPA/DOPE 
+ MgHECSPz 2.1×10-4 M 
535a 120a 35 
DOPA/DOPE 
+ MgHECSPz 4.2×10-4 M 
485a 80a 35 
a These data have been obtained with a slightly different simulation procedure, as 
detailed in the text. 
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Captions to figures 
 
 
Figure 1. Molecular structure of [2,3,7,8,12,13,17,18-octakis-(1,2-dicarba-closo-dodecaboranyl)-
hexylthio-5,10,15,20-porphyrazine]magnesium(II), MgHECSPz. Hydrogen atoms are omitted for the 
sake of clarity. 
 
Figure 2. UV-Visible spectrum of MgHECSPz (6.2·10-6M) at room temperature in CHCl3 (thin line) and 
CHCl3/MeOH (99:1 v/v) (tick line).  
 
Figure 3. Zeta Potential of DOTAP/DOPE (A), DOPA/DOPE (B) and DOPC/DOPE (C) liposomes as a 
function of the nominal content of MgHECSPz.  
 
Figure 4. SAXS curves of DOPA/DOPE series. (a) the three experimental curves: black squares: pure 
liposomes; red squares: liposomes with 2.1×10-4 M MgHECSPz; green squares: liposomes with 
4.2×10-4 M MgHECSPz.; (b-d) the experimental (square symbols as above) and the corresponding 
fitting (solid lines) curves for plain (b) and loaded (c, d) samples. 
 
Figure 5. Experimental SAXS curves and fitting of DOPC/DOPE liposomes. Black squares: pure 
liposomes; red squares: liposomes with 2.1×10-4 M MgHECSPz; green squares: liposomes with 
4.2×10-4 M MgHECSPz. Solid line: fitting curve. 
 
Figure 6. Experimental SANS curve (empty squares) and fitting (filled circles) of pure DOTAP/DOPE 
liposomes. 
 
Figure 7. SANS curves of DOPA/DOPE series. (a) the three experimental curves: black squares: pure 
liposomes; red squares: liposomes with 2×10-4 M MgHECSPz; green squares: liposomes with 4×10-4 
M MgHECSPz.; (b-d) the experimental (square symbols, as above) and the corresponding fitting (filled 
circles) curves for plain (b) and loaded (c, d) vectors.  
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Figure 1. Molecular structure of [2,3,7,8,12,13,17,18-octakis-(1,2-dicarba-closo-dodecaboranyl)-
hexylthio-5,10,15,20-porphyrazine]magnesium(II), MgHECSPz. Hydrogen atoms are omitted for the 
sake of clarity. 
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Figure 2. UV-Visible spectrum of MgHECSPz (6.2·10-6M) at room temperature in CHCl3 (dashed line) 
and CHCl3/MeOH (99:1 v/v) (full line).  
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Figure 3. Zeta Potential of DOTAP/DOPE (A), DOPA/DOPE (B) and DOPC/DOPE (C) liposomes as a 
function of the nominal content of MgHECSPz.  
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Figure 4. SAXS curves of DOPA/DOPE series. (a) the three experimental curves: black squares: pure 
liposomes; red squares: liposomes with 2.1×10-4 M MgHECSPz; green squares: liposomes with 
4.2×10-4 M MgHECSPz.; (b-d) the experimental (square symbols as above) and the corresponding 
fitting (solid lines) curves for plain (b) and loaded (c, d) samples. 
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Figure 5. Experimental SAXS curves and fitting of DOPC/DOPE liposomes. Black squares: pure 
liposomes; red squares: liposomes with 2.1×10-4 M MgHECSPz; green squares: liposomes with 
4.2×10-4 M MgHECSPz. Solid line: fitting curve. 
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Figure 6. Experimental SANS curve (empty squares) and fitting (filled circles) of pure DOTAP/DOPE 
liposomes. 
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Figure 7. SANS curves of DOPA/DOPE series. (a) the three experimental curves: black squares: pure 
liposomes; red squares: liposomes with 2×10-4 M MgHECSPz; green squares: liposomes with 4×10-4 
M MgHECSPz.; (b-d) the experimental (square symbols, as above) and the corresponding fitting (filled 
circles) curves for plain (b) and loaded (c, d) vectors.  
 
